Leadership and Strategy-Technology Strategy: Leading Cortechs.ai's technological direction, aligning initiatives with business goals to drive innovation in radiology and clinical care.-Product Management: Managing full product lifecycle from conception to regulatory clearance and post-market surveillance, using agile methodologies and best practices.-Team Leadership: Mentoring a high-performing team of AI/ML engineers, product managers, data scientists, platform architects, and software developers. Fostering a culture of innovation and continuous improvement.-Change Management: Guiding teams through organizational and technological transformations, ensuring smooth transitions and sustained performance improvements.Technical Expertise-AI/ML Imaging Applications: Developed FDA-cleared and CE-marked AI/ML products in neurology and oncology, enhancing diagnostic accuracy and patient outcomes.-Technology Infrastructure: Implementing strategies for automating and productionalizing machine learning applications, ensuring efficiency and reliability (MLOps/DevOps).-Cloud-Based Platforms: Designing secure, scalable, HIPAA-compliant cloud platforms for seamless deployment of AI applications in clinical workflows.Additional Skills-Strategic Partnerships: Building and maintaining alliances with key stakeholders to drive collaborative innovation and market expansion.-Regulatory Expertise: Achieving FDA and CE approvals by navigating complex regulatory landscapes and ensuring products meet stringent standards.-R&D Management: Secured multiple multi-year, multi-million dollar NIH SBIR FastTrack awards, driving innovation through successful grant proposals and project management.-IP Management: Developing robust IP and patent strategies to protect and leverage technological advancements.-Cross-Functional Collaboration: Collaborating with marketing, sales, and operations teams to ensure holistic product development and successful market integration.

Founding Chief Executive at HealthLytixHealthLytix is a pioneering healthcare technology company transforming the fields of genetics and medical imaging by developing advanced clinical tools for risk prediction and early diagnosis.Key Achievements:Company Formation and Leadership: Founded HealthLytix and successfully secured $4M in seed capital. Recruited and led a high-performing team of technical and business leaders.Product Development and Launch: Spearheaded the development and market introduction of two FDA-cleared medical device software applications, significantly advancing clinical diagnostics.Quality Management: Established and executed an Agile Quality Management System, ensuring compliance and fostering a culture of continuous improvement.Technical Infrastructure: Designed and implemented a robust technical infrastructure to support high-growth engineering teams and the deployment of modern software practices.Strategic Exit: Orchestrated the successful acquisition of HealthLytix by CorTechs Labs, Inc. in May 2020, delivering a successful exit and continued growth for the company.

Co-founded ZepMed and created CT CoPilot® software for automated quantitative image analysis of head computed tomography (CT) images. - Lead corporate strategy, business development, FDA regulatory submissions, software development, IP.- Architected and developed CT CoPilot® software and secured 510(k) clearances.

As Director of Imaging Technology at the Center for Translational Imaging and Precision Medicine (CTIPM) at UC San Diego, I was responsible for leading a team of scientists and engineers to develop next-generation medical imaging technologies and quantitative AI/ML solutions to address clinical needs for radiologists and referring physicians.- Lead technical team to develop novel AI/ML imaging solutions that address clinical pain points.- Architected AI platform for automated delivery of imaging applications into clinical workflows.- Served as both an external and internal advocate for the adoption of new imaging technologies.- Liaison between clinical stakeholders, hospital IT, researchers, and software engineers. - Inventor and developer of numerous patented medical imaging technologies including Restriction Spectrum Imaging (RSI) for non-invasive quantitative tissue microstructure imaging using diffusion MRI, and Prospective Real-time Motion Correction for MRI (PROMO).

Develop software solutions and novel imaging biomarkers for quantitative radiology applications.

Developed PROspective MOtion correction technique (PROMO) for real-time motion correction in MRI, and Restriction Spectrum Imaging (RSI) for quantification of tissue microstructure using diffusion MRI.

Graduated student in Cognitive Science. Supervised by: Anders Dale, Marta Kutas, Rick Buxton, Terry Jernigan.Thesis titled: "Quantitative Diffusion Magnetic Resonance Imaging of the Brain: Validation, Acquisition, and Analysis"